These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22511874)

  • 1. Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.
    Pastrana DV; Brennan DC; Cuburu N; Storch GA; Viscidi RP; Randhawa PS; Buck CB
    PLoS Pathog; 2012; 8(4):e1002650. PubMed ID: 22511874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.
    Pastrana DV; Ray U; Magaldi TG; Schowalter RM; Çuburu N; Buck CB
    J Virol; 2013 Sep; 87(18):10105-13. PubMed ID: 23843634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.
    Peretti A; Geoghegan EM; Pastrana DV; Smola S; Feld P; Sauter M; Lohse S; Ramesh M; Lim ES; Wang D; Borgogna C; FitzGerald PC; Bliskovsky V; Starrett GJ; Law EK; Harris RS; Killian JK; Zhu J; Pineda M; Meltzer PS; Boldorini R; Gariglio M; Buck CB
    Cell Host Microbe; 2018 May; 23(5):628-635.e7. PubMed ID: 29746834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy.
    Solis M; Velay A; Porcher R; Domingo-Calap P; Soulier E; Joly M; Meddeb M; Kack-Kack W; Moulin B; Bahram S; Stoll-Keller F; Barth H; Caillard S; Fafi-Kremer S
    J Am Soc Nephrol; 2018 Jan; 29(1):326-334. PubMed ID: 29042457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.
    Wunderink HF; de Brouwer CS; van der Meijden E; Pastrana DV; Kroes ACM; Buck CB; Feltkamp MCW
    J Clin Virol; 2019 Jan; 110():22-28. PubMed ID: 30529638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Pretransplant BK Polyomavirus Antibody Status with BK Polyomavirus Infection After Kidney Transplantation: A Prospective Cohort Pilot Study of 47 Transplant Recipients.
    Hisadome Y; Noguchi H; Nakafusa Y; Sakihama K; Mei T; Kaku K; Okabe Y; Masutani K; Ohara Y; Ikeda K; Oda Y; Nakamura M
    Transplant Proc; 2020; 52(6):1762-1768. PubMed ID: 32611487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques.
    Peretti A; Scorpio DG; Kong WP; Pang YS; McCarthy MP; Ren K; Jackson M; Graham BS; Buck CB; McTamney PM; Pastrana DV
    Vaccine; 2023 Mar; 41(10):1735-1742. PubMed ID: 36764908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
    Schachtner T; Zaks M; Kahl A; Reinke P
    Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients.
    Demey B; Descamps V; Presne C; Helle F; Francois C; Duverlie G; Castelain S; Brochot E
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.
    Comoli P; Cioni M; Basso S; Gagliardone C; Potenza L; Verrina E; Luppi M; Zecca M; Ghiggeri GM; Ginevri F
    Clin Dev Immunol; 2013; 2013():256923. PubMed ID: 24000288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyomavirus-associated nephropathy: update on BK virus-specific immunity.
    Comoli P; Binggeli S; Ginevri F; Hirsch HH
    Transpl Infect Dis; 2006 Jun; 8(2):86-94. PubMed ID: 16734631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
    Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
    J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation.
    Bae H; Jung S; Chung BH; Yang CW; Oh EJ
    Front Immunol; 2023; 14():1243912. PubMed ID: 37809095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients.
    Velay A; Solis M; Benotmane I; Gantner P; Soulier E; Moulin B; Caillard S; Fafi-Kremer S
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population.
    Hejtmánková A; Roubalová K; Forejtová A; Žáčková Suchanová J; Forstová J; Viklický O; Španielová H
    J Med Virol; 2019 May; 91(5):856-864. PubMed ID: 30609063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic Acid Tests for BK Polyomavirus Is Critical in Renal Transplant Recipients.
    Chang YL; Cheng YT; Chen TC; Chien YS; Lee WC; Shen YC
    Transplant Proc; 2018 Oct; 50(8):2489-2492. PubMed ID: 30316383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV-associated nephropathy.
    Naef B; Nilsson J; Wuethrich RP; Mueller TF; Schachtner T
    Transpl Int; 2021 Aug; 34(8):1481-1493. PubMed ID: 33872427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.